Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 039026/0455 | |
| Pages: | 17 |
| | Recorded: | 06/28/2016 | | |
| Attorney Dkt #: | PAT056009-US-PCT |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
02/08/2022
|
Application #:
|
15104601
|
Filing Dt:
|
06/15/2016
|
|
Publication #:
|
|
Pub Dt:
|
03/02/2017
| | | | |
|
Title:
|
NOVEL EUKARYOTIC CELLS AND METHODS FOR RECOMBINANTLY EXPRESSING A PRODUCT OF INTEREST
|
|
|
Assignee
|
|
|
|
|
| LICHTSTRASSE 35 |
| BASEL, SWITZERLAND 4056 |
|
|
Correspondence name and address
|
| |
JIM LYNCH
|
| |
NOVARTIS PHARMACEUTICALS CORPORATION
|
| |
ONE HEALTH PLAZA, BLDG 433
|
| |
EAST HANOVER, NJ 07936
|
Search Results as of:
05/24/2024 10:37 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
